Tsubakio T, Tani P, Woods V L, McMillan R
Department of Basic and Clinical Research, Scripps Clinic and Research Foundation, La Jolla, California.
Br J Haematol. 1987 Nov;67(3):345-8. doi: 10.1111/j.1365-2141.1987.tb02355.x.
Some patients with chronic immune thrombocytopenic purpura have autoantibodies to the platelet glycoprotein IIb/IIIa (GPIIb/IIIa) complex. To determine whether these autoantibodies are directed towards the same or different epitopes, we evaluated the ability of four murine monoclonal anti-GPIIb/IIIa antibodies specific for different epitopes to block autoantibody binding. We noted a variation in blocking patterns among autoantibodies from patients with chronic ITP. In addition, we were able to map the relative epitope locations of both the autoantibodies and the monoclonal antibodies. These data show that the anti-GPIIb/IIIa monoclonal autoantibodies in chronic ITP are directed towards different epitopes.
一些慢性免疫性血小板减少性紫癜患者存在针对血小板糖蛋白IIb/IIIa(GPIIb/IIIa)复合物的自身抗体。为了确定这些自身抗体是否针对相同或不同的表位,我们评估了四种对不同表位具有特异性的鼠抗GPIIb/IIIa单克隆抗体阻断自身抗体结合的能力。我们注意到慢性ITP患者自身抗体之间的阻断模式存在差异。此外,我们能够绘制自身抗体和单克隆抗体的相对表位位置。这些数据表明,慢性ITP中的抗GPIIb/IIIa单克隆自身抗体针对不同的表位。